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Neonatal thrombocytosis is a very rare phenomenon in infants born to addict mothers. It can be due to 
opioids withdrawal and occurs a few days after delivery. The etiology is unknown and it is eradicated 
gradually without any complication.  
The reported neonate was born to a heroin addict mother who has used methadone during pregnancy. The 
neonate was admitted in 14th day of life in neonatal intensive care unit (NICU) with the diagnosis of 
withdrawal syndrome and supportive care was administered for him. Thrombocytosis was detected in 
routine lab tests. There was not any reason for it except his mother’s addiction. The platelet count was 
1,168,000 in the first day and decreased gradually during 28 days to 739,000. There was not any 
complication and no special treatment was administered. This case indicates that thrombocytosis may 
happen as a part of neonatal abstinence syndrome and is eradicated without any complication. 
Keywords: Thrombocytosis, Neonatal abstinence syndrome, Opioids, Methadone 
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